Market Herald logo


Be the first with the news that moves the market
  • BevCanna (BEV) has signed a non-binding letter of intent with Mota Ventures to introduce its products to the European market
  • Each company will hold a 50 per cent stake in the joint venture
  • The agreement has an initial term of five years, with the option for a further five-year renewal
  • BevCanna also announced a marketing and investor relations agreement with AG
  • Shares in the company are currently up 9.86 per cent to C$0.39, with a market cap of C$18.42 million

BevCanna (BEV) has signed a letter of intent with Mota Ventures to manufacture, market and distribute BevCanna-branded drinks.

Each company will hold a 50 per cent stake in the joint venture, with an even split of associated costs.

In an effort to gain traction in the European market, BevCanna has agreed to provide house brands, formulations, proprietary IP for its water-soluble powders and manufacturing expertise. 

Likewise, Mota Ventures will provide European-based production, marketing and distribution infrastructure.

The joint venture will have an initial term of five years and a subsequent five-year renewal option.

The initial five-year period is expected to be largely occupied by a comprehensive launch program, with commercial regions expected to include Spain, Portugal, Austria, Germany, France and the UK.

BevCanna and Mota Ventures will work collaboratively to determine the optimum product launch mix and timing for each specific market, based on existing offerings and market dynamics.

“This agreement will leverage BevCanna’s expertise in manufacturing infused cannabinoid products and Mota’s reputation for creating safe, effective, high quality CBD products,” said BevCanna’s Chief Strategy Officer, John Campbell.

“The European health and wellness market is growing vastly, and Europeans are eager to see more reputable North American brands and options from trust-worthy producers, and we’re excited to be able to provide that.”

A definitive agreement is expected to be formulated over the next 30 days and is subject to a number of conditions, including due diligence by both companies, demonstrated ability for BevCanna to transfer its trademarks to the European market, and approval from each party’s Board of Directors.

Further to the joint venture announcement, BevCanna also revealed that it has entered into a marketing and investor relation agreement with AG.

The consultancy will provide corporate branding, marketing, online corporate communications and investor relations services for a term of one month.

Total consideration for the one-month period is valued at approximately C$73,000.

Shares in BevCanna are currently up 9.86 per cent to C$0.39, with a market cap of C$18.42 million.

More From The Market Herald
Innocan Pharma - CEO Iris Bincovish

" Innocan Pharma (CSE:INNO) patent application for treatment of psoriasis of the scalp goes national

Innocan Pharma’s (INNO) patent application, which claims cannabinoid-based topical compositions can treat psoriasis of the scalp, has reached the national phase.

" Pure Extracts (CSE:PULL) new cured resin vape carts PO from Ontario Cannabis Store

Pure Extracts (PULL) receives a purchase order (PO) from the Ontario Cannabis Store (OCS) for its new, cured resin, 1 g vape carts.

" Decibel (TSXV:DB) announces international expansion of Qwest Brand

Decibel (DB) has secured a supply agreement with Breath of Life International to launch Decibel’s Qwest brand and cannabis products in Israel.

" The BC Bud Corporation (CSE:BCBC) begins trading on the OTCQB

Common shares of The BC Bud Corporation (BCBC) have begun trading on the OTCQB under the symbol WFGCF.